Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...

A new drug called amycretin is stepping into the spotlight, boasting impressive results that have both researchers and those ...

Ozempic maker Novo Nordisk has developed a pill that can cause weight loss of up to 13% in three months, according to new ...

The release of early-stage data on three oral weight loss drug candidates hints at which companies have the strongest hand, ...

New weight-loss pills cause weight loss almost four times as fast as Ozempic and similar injectable treatments ...

Amycretin, an oral weight loss drug, led to up to 13% body weight reduction in three months, showing potential for continued ...

Kourtney Kardashian’s new “GLP-1 Daily” pill is the latest product to capitalize on the weight loss drug craze.

The drug manufacturer has developed a pill that could bring about weight loss of as much as 13% in three months, according to ...

25mg – white, triangular-shaped, film-coated tablets debossed with “I” on ... men over age 40, hypertension, obesity, diabetes, smokers, strong family history). Monitor cardiovascular ...

Lilly is investing broadly in obesity and has 11 new molecules currently ... Semaglutide is approved as Ozempic pre-filled pen and Rybelsus oral tablet for type II diabetes and as Wegovy injection ...

Novo Nordisk A/S's shares have stalled recently, but this looks like a natural digestion of gains from prior years. Click for ...